A brand new bag. Trauma-care revolution among benefits touted as blood substitute enters critical phase of clinical trials.
Becker
Cinda
C
D001802:Blood Substitutes / Q000191:economics / Q000592:standards / Q000627:therapeutic use*; D001803:Blood Transfusion; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D004638:Emergency Treatment; D006454:Hemoglobins / Q000191:economics / Q000592:standards / Q000627:therapeutic use*; D006801:Humans; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration; D014947:Wounds and Injuries / Q000188:drug therapy
D001802:Blood Substitutes; D006454:Hemoglobins; C037158:polyhemoglobin